Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients.

Jean-Pascal H MachielsCarlos Gomez-RocaJean-Marie MichotDmitriy ZamarinTara MitchellGaetan CatalaLauriane EberstWolfgang JacobAnna-Maria JeggMichael A CannarileCarl WatsonGalina BabitzkiKonstanty KorskiIrina KlamanPriscila TeixeiraSabine HovesCarola RiesGeorgina Meneses-LorenteFrancesca MichielinRandolph ChristenDominik RüttingerMartin WeisserJean-Pierre DelordPhilippe Cassier

Published in: Journal for immunotherapy of cancer (2021)

NCT02760797.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported